Tech Company Financing Transactions
Noven Pharmaceuticals Funding Round
Enterprise Partners Venture Capital, KTB Ventures and Meritech Capital Partners participated in a $1.8 million capital raise for Noven Pharmaceuticals. The financing closed on 12/31/2007.
Transaction Overview
Company Name
Announced On
12/31/2007
Transaction Type
Venture Equity
Amount
$1,800,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11960 SW 144th St.
Miami, FL 33186
USA
Miami, FL 33186
USA
Phone
Website
Email Address
Overview
Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Naruhito Higo
Chief Financial Officer
John Choi
Chief Operating Officer
Joel Lippman
Vice President
Shinichi Sato
VP - Operations
Mark Jackson
Browse more venture capital transactions:
Prev: 12/31/2007: Efficas venture capital transaction
Next: 12/31/2007: Moodlerooms venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs